Even as the prevalence of diabetes rose over the past decade, the treatment costs borne by patients actually declined, according to a new Commonwealth Fund–supported study by Peter Cunningham of Virginia Commonwealth University and Emily Carrier of Mathematica Policy Research (American Journal of Managed Care, Feb. 2014).